ALK1 receptor and ligand antagonists and uses thereof

Details for Australian Patent Application No. 2007317926 (hide)

Owner Acceleron Pharma, Inc.

Inventors Pearsall, Robert Scott; Grinberg, Asya; Seehra, Jasbir; Knopf, John; Kumar, Ravindra

Agent Davies Collison Cave

Pub. Number AU-A-2007317926

PCT Pub. Number WO2008/057461

Priority 60/856,592 02.11.06 US

Filing date 2 November 2007

Wipo publication date 15 May 2008

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/057461 Priority application(s): WO2008/057461

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317938-Media material analysis of continuing article portions

2007317921-Methods of using SAHA and Bortezomib for treating multiple myeloma